News
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for duloxetine delayed release capsules for Current Good Manufacturing Practice (CGMP) deviations, affecting 50 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for duloxetine delayed release capsules for Current Good Manufacturing Practice (CGMP) deviations, affecting 50 bottles.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network